Domestic chronic therapy segments remain key focus areas

Torrent Pharma’s latest earnings concall highlighted key growth drivers, strategic priorities, and margin outlook for the coming quarters. The company emphasized strong growth potential in the domestic pharmaceutical market, particularly in chronic therapy segments such as cardiac, diabetes, and CNS treatments. Management reiterated its focus on expanding branded generics and